p53 isoforms regulate astrocyte-mediated neuroprotection and neurodegeneration
Jazyk angličtina Země Anglie, Velká Británie Médium print-electronic
Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem
PubMed
27104929
PubMed Central
PMC5072428
DOI
10.1038/cdd.2016.37
PII: cdd201637
Knihovny.cz E-zdroje
- MeSH
- alternativní sestřih MeSH
- Alzheimerova nemoc metabolismus patologie MeSH
- amyotrofická laterální skleróza metabolismus patologie MeSH
- astrocyty cytologie účinky léků metabolismus MeSH
- autofagie účinky léků MeSH
- genetické vektory genetika metabolismus MeSH
- interleukin-6 genetika metabolismus MeSH
- kokultivační techniky MeSH
- kultivované buňky MeSH
- leupeptiny farmakologie MeSH
- lidé MeSH
- malá interferující RNA metabolismus MeSH
- mozek metabolismus patologie MeSH
- nádorový supresorový protein p53 antagonisté a inhibitory genetika metabolismus MeSH
- neurony cytologie metabolismus MeSH
- neuroprotekce fyziologie MeSH
- protein - isoformy antagonisté a inhibitory genetika metabolismus MeSH
- RNA interference MeSH
- sekvestosom 1 antagonisté a inhibitory genetika metabolismus MeSH
- serin-arginin sestřihové faktory antagonisté a inhibitory genetika metabolismus MeSH
- stárnutí buněk MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Research Support, N.I.H., Extramural MeSH
- Názvy látek
- benzyloxycarbonylleucyl-leucyl-leucine aldehyde MeSH Prohlížeč
- interleukin-6 MeSH
- leupeptiny MeSH
- malá interferující RNA MeSH
- nádorový supresorový protein p53 MeSH
- protein - isoformy MeSH
- sekvestosom 1 MeSH
- serin-arginin sestřihové faktory MeSH
- SQSTM1 protein, human MeSH Prohlížeč
- SRSF3 protein, human MeSH Prohlížeč
Bidirectional interactions between astrocytes and neurons have physiological roles in the central nervous system and an altered state or dysfunction of such interactions may be associated with neurodegenerative diseases, such as Alzheimer's disease (AD) and amyotrophic lateral sclerosis (ALS). Astrocytes exert structural, metabolic and functional effects on neurons, which can be either neurotoxic or neuroprotective. Their neurotoxic effect is mediated via the senescence-associated secretory phenotype (SASP) involving pro-inflammatory cytokines (e.g., IL-6), while their neuroprotective effect is attributed to neurotrophic growth factors (e.g., NGF). We here demonstrate that the p53 isoforms Δ133p53 and p53β are expressed in astrocytes and regulate their toxic and protective effects on neurons. Primary human astrocytes undergoing cellular senescence upon serial passaging in vitro showed diminished expression of Δ133p53 and increased p53β, which were attributed to the autophagic degradation and the SRSF3-mediated alternative RNA splicing, respectively. Early-passage astrocytes with Δ133p53 knockdown or p53β overexpression were induced to show SASP and to exert neurotoxicity in co-culture with neurons. Restored expression of Δ133p53 in near-senescent, otherwise neurotoxic astrocytes conferred them with neuroprotective activity through repression of SASP and induction of neurotrophic growth factors. Brain tissues from AD and ALS patients possessed increased numbers of senescent astrocytes and, like senescent astrocytes in vitro, showed decreased Δ133p53 and increased p53β expression, supporting that our in vitro findings recapitulate in vivo pathology of these neurodegenerative diseases. Our finding that Δ133p53 enhances the neuroprotective function of aged and senescent astrocytes suggests that the p53 isoforms and their regulatory mechanisms are potential targets for therapeutic intervention in neurodegenerative diseases.
Department of Neurology Georgetown University Medical Center Washington DC 20007 USA
Department of Pathology Georgetown University Medical Center Washington DC 20007 USA
p53 Laboratory Biomedical Sciences Institutes Singapore 138648 Singapore
Zobrazit více v PubMed
Wimo A, Prince M. World Alzheimer Report 2010: The Global Economic Impact of Dementia. Alzheimer's Disease International: London, UK, 2010.
Larkindale J, Yang W, Hogan PF, Simon CJ, Zhang Y, Jain A et al. Cost of illness for neuromuscular diseases in the United States. Muscle Nerve 2014; 49: 431–438. PubMed
Barres BA. The mystery and magic of glia: a perspective on their roles in health and disease. Neuron 2008; 60: 430–440. PubMed
Verkhratsky A, Sofroniew MV, Messing A, deLanerolle NC, Rempe D, Rodríguez JJ et al. Neurological diseases as primary gliopathies: a reassessment of neurocentrism. ASN Neuro 2012; 4: 131–149. PubMed PMC
Furman JL, Sama DM, Gant JC, Beckett TL, Murphy MP, Bachstetter AD et al. Targeting astrocytes ameliorates neurologic changes in a mouse model of Alzheimer's disease. J Neurosci 2012; 32: 16129–16140. PubMed PMC
Das MM, Svendsen CN. Astrocytes show reduced support of motor neurons with aging that is accelerated in a rodent model of ALS. Neurobiol Aging 2014; 36: 1130–1139. PubMed
Haidet-Phillips AM, Hester ME, Miranda CJ, Meyer K, Braun L, Frakes A et al. Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nat Biotechnol 2011; 29: 824–828. PubMed PMC
Jia JP, Meng R, Sun YX, Sun WJ, Ji XM, Jia LF. Cerebrospinal fluid tau, Abeta1-42 and inflammatory cytokines in patients with Alzheimer's disease and vascular dementia. Neurosci Lett 2005; 383: 12–16. PubMed
Campbell IL, Abraham CR, Masliah E, Kemper P, Inglis JD, Oldstone MB et al. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc Natl Acad Sci USA 1993; 90: 10061–10065. PubMed PMC
Farina C, Aloisi F, Meinl E. Astrocytes are active players in cerebral innate immunity. Trends Immunol 2007; 28: 138–145. PubMed
Nagatsu T, Mogi M, Ichinose H, Togari A. Changes in cytokines and neurotrophins in Parkinson's disease. J Neural Transm Suppl 2000: 277–290. PubMed
Tuszynski MH. Nerve growth factor gene therapy in Alzheimer disease. Alzheimer Dis Assoc Disord 2007; 21: 179–189. PubMed
Erickson KI, Prakash RS, Voss MW, Chaddock L, Heo S, McLaren M et al. Brain-derived neurotrophic factor is associated with age-related decline in hippocampal volume. J Neurosci 2010; 30: 5368–5375. PubMed PMC
Brenner M, Johnson AB, Boespflug-Tanguy O, Rodriguez D, Goldman JE, Messing A. Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease. Nat Genet 2001; 27: 117–120. PubMed
Miller RG, Mitchell JD, Lyon M, Moore DH. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database Syst Rev 2007: CD001447. PubMed
Rayess H, Wang MB, Srivatsan ES. Cellular senescence and tumor suppressor gene p16. Int J cancer 2012; 130: 1715–1725. PubMed PMC
Roninson IB. Oncogenic functions of tumour suppressor p21Waf1/Cip1/Sdi1: association with cell senescence and tumour-promoting activities of stromal fibroblasts. Cancer Lett 2002; 179: 1–14. PubMed
Debacq-Chainiaux F, Erusalimsky JD, Campisi J, Toussaint O. Protocols to detect senescence-associated beta-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo. Nat Protoc 2009; 4: 1798–1806. PubMed
Campisi J. Aging, cellular senescence, and cancer. Annu Rev Physiol 2013; 75: 685–705. PubMed PMC
Sohn JJ, Schetter AJ, Yfantis HG, Ridnour LA, Horikawa I, Khan MA et al. Macrophages, nitric oxide and microRNAs are associated with DNA damage response pathway and senescence in inflammatory bowel disease. PLoS ONE 2012; 7: e44156. PubMed PMC
Wang C, Jurk D, Maddick M, Nelson G, Martin-Ruiz C, von Zglinicki T. DNA damage response and cellular senescence in tissues of aging mice. Aging Cell 2009; 8: 311–323. PubMed
Coppé J-P, Desprez P-Y, Krtolica A, Campisi J. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol 2010; 5: 99–118. PubMed PMC
Demaria M, Ohtani N, Youssef SA, Rodier F, Toussaint W, Mitchell JR et al. An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA. Dev Cell 2014; 31: 722–733. PubMed PMC
Serrano M. Senescence helps regeneration. Dev Cell 2014; 31: 671–672. PubMed
Banito A, Lowe SW. A new development in senescence. Cell 2013; 155: 977–978. PubMed PMC
Storer M, Mas A, Robert-Moreno A, Pecoraro M, Ortells MC, Di Giacomo V et al. Senescence is a developmental mechanism that contributes to embryonic growth and patterning. Cell 2013; 155: 1119–1130. PubMed
Muñoz-Espín D, Cañamero M, Maraver A, Gómez-López G, Contreras J, Murillo-Cuesta S et al. Programmed cell senescence during mammalian embryonic development. Cell 2013; 155: 1104–1118. PubMed
Zilfou JT, Lowe SW. Tumor suppressive functions of p53. Cold Spring Harb Perspect Biol 2009; 1: a001883. PubMed PMC
Bourdon J-C, Fernandes K, Murray-Zmijewski F, Liu G, Diot A, Xirodimas DP et al. p53 isoforms can regulate p53 transcriptional activity. Genes Dev 2005; 19: 2122–2137. PubMed PMC
Fujita K, Mondal AM, Horikawa I, Nguyen GH, Kumamoto K, Sohn JJ et al. p53 isoforms Delta133p53 and p53beta are endogenous regulators of replicative cellular senescence. Nat Cell Biol 2009; 11: 1135–1142. PubMed PMC
Mondal AM, Horikawa I, Pine SR, Fujita K, Morgan KM, Vera E et al. p53 isoforms regulate aging- and tumor-associated replicative senescence in T lymphocytes. J Clin Invest 2013; 123: 5247–5257. PubMed PMC
Mendrysa SM, Ghassemifar S, Malek R. p53 in the CNS: perspectives on development, stem cells, and cancer. Genes Cancer 2011; 2: 431–442. PubMed PMC
Kurtkaya-Yapicier O, Scheithauer BW, Hebrink D, James CD. p53 in nonneoplastic central nervous system lesions: an immunohistochemical and genetic sequencing study. Neurosurgery 2002; 51: 1246–1254; discussion 1254–5. PubMed
Bitto A, Sell C, Crowe E, Lorenzini A, Malaguti M, Hrelia S et al. Stress-induced senescence in human and rodent astrocytes. Exp Cell Res 2010; 316: 2961–2968. PubMed
Surget S, Khoury MP, Bourdon J-C. Uncovering the role of p53 splice variants in human malignancy: a clinical perspective. Onco Targets Ther 2013; 7: 57–68. PubMed PMC
Horikawa I, Fujita K, Jenkins LM, Hiyoshi Y, Mondal AM, Vojtesek B et al. Autophagic degradation of the inhibitory p53 isoform Δ133p53α as a regulatory mechanism for p53-mediated senescence. Nat Commun 2014; 5: 4706. PubMed PMC
Mizushima N, Yoshimori T, Levine B. Methods in mammalian autophagy research. Cell 2010; 140: 313–326. PubMed PMC
Tanida I, Ueno T, Kominami E. LC3 and sutophagy. Methods Mol Biol 2008; 445: 77–88. PubMed
Ferenczy MW, Johnson KR, Steinberg SM, Marshall LJ, Monaco MC, Beschloss AM et al. Clonal immortalized human glial cell lines support varying levels of JC virus infection due to differences in cellular gene expression. J Neuroimmune Pharmacol 2013; 8: 1303–1319. PubMed
Major EO, Miller AE, Mourrain P, Traub RG, de Widt E, Sever J. Establishment of a line of human fetal glial cells that supports JC virus multiplication. Proc Natl Acad Sci USA 1985; 82: 1257–1261. PubMed PMC
Johansen T, Lamark T. Selective autophagy mediated by autophagic adapter proteins. Autophagy 2011; 7: 279–296. PubMed PMC
Wu WK, Wu YC, Yu L, Li ZJ, Sung JJY, Cho CH. Induction of autophagy by proteasome inhibitor is associated with proliferative arrest in colon cancer cells. Biochem Biophys Res Commun 2008; 374: 258–263. PubMed
Pandey UB, Nie Z, Batlevi Y, McCray BA, Ritson GP, Nedelsky NB et al. HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature 2007; 447: 859–863. PubMed
Tang Y, Horikawa I, Ajiro M, Robles AI, Fujita K, Mondal AM et al. Downregulation of splicing factor SRSF3 induces p53β, an alternatively spliced isoform of p53 that promotes cellular senescence. Oncogene 2013; 32: 2792–2798. PubMed PMC
Bernard H, Garmy-Susini B, Ainaoui N, Van Den Berghe L, Peurichard A, Javerzat S et al. The p53 isoform, Δ133p53α, stimulates angiogenesis and tumour progression. Oncogene 2013; 32: 2150–2160. PubMed
Marcel V, Fernandes K, Terrier O, Lane DP, Bourdon J-C. Modulation of p53β and p53γ expression by regulating the alternative splicing of TP53 gene modifies cellular response. Cell Death Differ 2014; 21: 1377–1387. PubMed PMC
Marcel V, Dichtel-Danjoy M-L, Sagne C, Hafsi H, Ma D, Ortiz-Cuaran S et al. Biological functions of p53 isoforms through evolution: lessons from animal and cellular models. Cell Death Differ 2011; 18: 1815–1824. PubMed PMC
Haidet-phillips AM, Hester ME, Miranda CJ, Meyer K, Braun L, Frakes A et al. Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nat Biotechnol 2012; 29: 824–828. PubMed PMC
Grunseich C, Zukosky K, Kats IR, Ghosh L, Harmison GG, Bott LC et al. Stem cell-derived motor neurons from spinal and bulbar muscular atrophy patients. Neurobiol Dis 2014; 70: 12–20. PubMed PMC
Zhao M, Su J, Head E, Cotman CW. Accumulation of caspase cleaved amyloid precursor protein represents an early neurodegenerative event in aging and in Alzheimer's disease. Neurobiol Dis 2003; 14: 391–403. PubMed
Kuilman T, Michaloglou C, Mooi WJ, Peeper DS. The essence of senescence. Genes Dev 2010; 24: 2463–2479. PubMed PMC
Pertusa M, García-Matas S, Rodríguez-Farré E, Sanfeliu C, Cristòfol R. Astrocytes aged in vitro show a decreased neuroprotective capacity. J Neurochem 2007; 101: 794–805. PubMed
Jiang T, Cadenas E. Astrocytic metabolic and inflammatory changes as a function of age. Aging Cell 2014; 13: 1059–1067. PubMed PMC
Hefti F. Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections. J Neurosci 1986; 6: 2155–2162. PubMed PMC
Wine RN, McPherson CA, Harry GJ. IGF-1 and pAKT signaling promote hippocampal CA1 neuronal survival following injury to dentate granule cells. Neurotox Res 2009; 16: 280–292. PubMed PMC
Genis L, Dávila D, Fernandez S, Pozo-Rodrigálvarez A, Martínez-Murillo R, Torres-Aleman I. Astrocytes require insulin-like growth factor I to protect neurons against oxidative injury. F1000Res 2014; 3: 28. PubMed PMC
Lowe JM, Menendez D, Bushel PR, Shatz M, Kirk EL, Troester MA et al. p53 and NF-κB coregulate proinflammatory gene responses in human macrophages. Cancer Res 2014; 74: 2182–2192. PubMed PMC
Levine AJ, Feng Z, Mak TW, You H, Jin S. Coordination and communication between the p53 and IGF-1-AKT-TOR signal transduction pathways. Genes Dev 2006; 20: 267–275. PubMed
Gong L, Gong H, Pan X, Chang C, Ou Z, Ye S et al. p53 isoform Δ113p53/Δ133p53 promotes DNA double-strand break repair to protect cell from death and senescence in response to DNA damage. Cell Res 2015; 25: 351–369. PubMed PMC
Ilieva H, Polymenidou M, Cleveland DW. Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J Cell Biol 2009; 187: 761–772. PubMed PMC
Marchetto MC, Muotri AR, Mu Y, Smith AM, Cezar GG, Gage FH. Non-cell-autonomous effect of human SOD1 G37R astrocytes on motor neurons derived from human embryonic stem cells. Cell Stem Cell 2008; 3: 649–657. PubMed
Heuer E, Rosen RF, Cintron A, Walker LC. Nonhuman primate models of Alzheimer-like cerebral proteopathy. Curr Pharm Des 2012; 18: 1159–1169. PubMed PMC
Muratore CR, Srikanth P, Callahan DG, Young-Pearse TL. Comparison and optimization of hiPSC forebrain cortical differentiation protocols. PLoS One 2014; 9: e105807. PubMed PMC
Brennand KJ, Simone A, Jou J, Gelboin-Burkhart C, Tran N, Sangar S et al. Modelling schizophrenia using human induced pluripotent stem cells. Nature 2011; 473: 221–225. PubMed PMC
Re-appraising the evidence for the source, regulation and function of p53-family isoforms
Radiation-induced astrocyte senescence is rescued by Δ133p53